Templier C - Search Results

1

Systematic skin examination in an acute geriatric unit: skin cancer prevalence.

Templier C, Boulanger E, Boumbar Y, Puisieux F, Dziwniel V, Mortier L, Beuscart JB. Templier C, et al. Clin Exp Dermatol. 2015 Jun;40(4):356-60. doi: 10.1111/ced.12562. Epub 2015 Jan 27. Clin Exp Dermatol. 2015. PMID: 25623526

2

[A "tattooed" lymph node mimicking metastatic melanoma].

Chaddouki A, Templier C, Desmedt E, Alkeraye S, Daussay D, Martin-Delassalle E, Guerreschi P, Mortier L. Chaddouki A, et al. Among authors: templier c. Ann Dermatol Venereol. 2013 Dec;140(12):802-4. doi: 10.1016/j.annder.2013.09.162. Epub 2013 Oct 22. Ann Dermatol Venereol. 2013. PMID: 24315229 French. No abstract available.

3

Persistent alopecia induced by vismodegib.

Alkeraye S, Maire C, Desmedt E, Templier C, Mortier L. Alkeraye S, et al. Among authors: templier c. Br J Dermatol. 2015 Jun;172(6):1671-1672. doi: 10.1111/bjd.13630. Epub 2015 Apr 1. Br J Dermatol. 2015. PMID: 25546344 No abstract available.

4

Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases.

Jacobsoone-Ulrich A, Jamme P, Alkeraye S, Dzwiniel V, Faure E, Templier C, Mortier L. Jacobsoone-Ulrich A, et al. Among authors: templier c. Melanoma Res. 2016 Apr;26(2):153-6. doi: 10.1097/CMR.0000000000000221. Melanoma Res. 2016. PMID: 26636908

5

Occurrence of vismodegib-induced cramps (muscular spasms) in the treatment of basal cell carcinoma: A prospective study in 30 patients.

Girard E, Lacour A, Abi Rached H, Ramdane N, Templier C, Dziwniel V, Desmedt E, Le Rhun E, Mortier L. Girard E, et al. Among authors: templier c. J Am Acad Dermatol. 2018 Jun;78(6):1213-1216.e2. doi: 10.1016/j.jaad.2017.11.045. Epub 2017 Dec 1. J Am Acad Dermatol. 2018. PMID: 29203435 No abstract available.

6

Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma.

Lamiaux M, Scalbert C, Lepesant P, Desmedt E, Templier C, Dziwniel V, Staumont-Sallé D, Mortier L. Lamiaux M, et al. Among authors: templier c. Melanoma Res. 2018 Oct;28(5):451-457. doi: 10.1097/CMR.0000000000000472. Melanoma Res. 2018. PMID: 29985833

7

Description of supportive care and feasibility of physical exercise program to improve quality of life in advanced melanoma patients.

Boileau M, Templier C, Massip E, Dehoux C, Dziwniel V, Fabre C, Thevenon A, Mortier L. Boileau M, et al. Among authors: templier c. Melanoma Res. 2023 Jun 1;33(3):230-238. doi: 10.1097/CMR.0000000000000889. Epub 2023 Mar 17. Melanoma Res. 2023. PMID: 36928055

8

Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma.

Boileau M, Dubois M, Pruvot C, Desmedt E, Templier C, Meyer N, Mirabel X, Mortier L. Boileau M, et al. Among authors: templier c. Clin Exp Dermatol. 2024 Aug 22;49(9):1024-1028. doi: 10.1093/ced/llae068. Clin Exp Dermatol. 2024. PMID: 38440960

9

Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma.

Sakji-Dupré L, Le Rhun E, Templier C, Desmedt E, Blanchet B, Mortier L. Sakji-Dupré L, et al. Among authors: templier c. Melanoma Res. 2015 Aug;25(4):302-5. doi: 10.1097/CMR.0000000000000162. Melanoma Res. 2015. PMID: 25933211

10

BRAF inhibitor discontinuation and rechallenge in advanced melanoma patients with a complete initial treatment response.

Desvignes C, Abi Rached H, Templier C, Drumez E, Lepesant P, Desmedt E, Mortier L. Desvignes C, et al. Among authors: templier c. Melanoma Res. 2017 Jun;27(3):281-287. doi: 10.1097/CMR.0000000000000350. Melanoma Res. 2017. PMID: 28240681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters